For US Healthcare Professionals Only
Filter
Fenfluramine Treatment in Adults With Developmental and Epileptic Encephalopathies: a Systematic Narrative Review
Population Pharmacokinetics of Fenfluramine and Its Active Metabolite, Norfenfluramine, in Patients With CDKL5 Deficiency Disorder
Streamlining the Process of Caregiving for a Loved One With Dravet or Lennox-Gastaut Syndrome
Fenfluramine-Associated Changes in Everyday Executive Functioning in Paediatric Patients With Lennox-Gastaut Syndrome: Post Hoc Analysis of a Phase III Trial
Challenges in Transitioning Adolescents with Rare and Complex Epilepsies from Paediatric to Adult Care: A Health System Policy Assessment
Healthcare Resource Utilisation, Antiseizure Medication Claims, and Treatment Persistence in Patients With Lennox-Gastaut Syndrome Receiving Fenfluramine in the United States
Impact of Disruptive Seizures, Sleep, and Behaviors on Activities of Daily Living and Communication in Individuals Aged 16 Years and Older with Developmental and Epileptic Encephalopathies
Design of a Phase III Randomised, Double-Blind, Placebo-Controlled Trial With an Open-Label Extension Evaluating the Efficacy and Safety of Fenfluramine in Patients With Rett Syndrome
Prospective evaluation of fenfluramine use in a cohort of pediatric and adult patients with Dravet syndrome
Patient and Caregiver Preferences for Acute Seizure Medications: A Quantitative Survey
Patient and Caregiver Perceptions of Acute Seizure Medications and the Rapid and Early Seizure Termination (REST) Approach: Qualitative Interviews
Strengthening the Dialogue: Advancing Patient-Provider Communication in Epilepsy Management
Association of Fenfluramine Treatment and Everyday Executive Functioning in Adult Patients With Lennox-Gastaut Syndrome
Non-Seizure Outcomes and Caregiver Burden in Patients With Dravet Syndrome and Lennox-Gastaut Syndrome Treated With Fenfluramine: Design of a Prospective, Multicentre, Non-Interventional Study
Seizure Control With Fenfluramine vs Placebo in Children and Adults With CDKL5 Deficiency Disorder: A Post Hoc Time-To-Event Analysis of Data From a Phase III, Randomised, Placebo-Controlled Trial
Mortality Rates and Risk Factors Among Patients With Lennox-Gastaut Syndrome or Dravet Syndrome
Examining Seizure-Free Days With Fenfluramine in Children and Adults With CDKL5 Deficiency Disorder: A Post Hoc Analysis of a Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial